G6PD and neuroblastoma: There were three cases of malignancy (acute myeloid leukemia, myelodysplastic syndrome and neuroblastoma, respectively) and three cases of benign hematologic diseases (chronic neutropenia, glucose-6-phosphate dehydrogenase (G6PD) deficiency and hereditary spherocytosis, respectively).